BioLargo’s Clyra Medical secures first stocking order for ViaCLYR

BioLargo (BLGO) announced that its subsidiary, Clyra Medical Technologies, Inc., has received its first commercial stocking order from Advanced Solution for ViaCLYR, Clyra’s FDA-cleared wound irrigation solution. The order marks the start of commercial distribution and represents Clyra’s transition from development-stage operations to early revenue generation. The stocking order initiates product availability through Advanced Solution’s national distribution platform, supporting sales to hospitals, clinics, and healthcare providers across the United States. BioLargo views this milestone as the first in a series of planned commercial and revenue-related announcements as Clyra advances its market rollout.